Cargando…

Comprehensive Serum Profiling for the Discovery of Epithelial Ovarian Cancer Biomarkers

FDA-cleared ovarian cancer biomarkers are limited to CA-125 and HE4 for monitoring and recurrence and OVA1, a multivariate panel consisting of CA-125 and four additional biomarkers, for referring patients to a specialist. Due to relatively poor performance of these tests, more accurate and broadly a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yip, Ping, Chen, Tzong-Hao, Seshaiah, Partha, Stephen, Laurie L., Michael-Ballard, Karri L., Mapes, James P., Mansfield, Brian C., Bertenshaw, Greg P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244467/ https://www.ncbi.nlm.nih.gov/pubmed/22216306 http://dx.doi.org/10.1371/journal.pone.0029533

Ejemplares similares

Development and Preliminary Evaluation of a Multivariate Index Assay for Ovarian Cancer
por: Amonkar, Suraj D., et al.
Publicado: (2009)

Discovery and Validation of Novel Biomarkers for Detection of Epithelial Ovarian Cancer
por: Kulbe, Hagen, et al.
Publicado: (2019)

Discovery of novel serum metabolic biomarkers in patients with polycystic ovarian syndrome and premature ovarian failure
por: Chen, Jiying, et al.
Publicado: (2021)

Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies
por: Timms, John F., et al.
Publicado: (2014)

Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer
por: Dutt, Mriga, et al.
Publicado: (2023)

Discovery of dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer
por: Nodin, Björn, et al.
Publicado: (2012)

Discovery of Ovarian Cancer Biomarkers in Serum Using NanoLC Electrospray Ionization TOF and FT-ICR Mass Spectrometry
por: Bergen, H. Robert, et al.
Publicado: (2004)

Exploring the Immunoproteome for Ovarian Cancer Biomarker Discovery
por: Martin, Karina, et al.
Publicado: (2011)

Utility of Comprehensive Serum Glycopeptide Spectra Analysis (CSGSA) for the Detection of Early Stage Epithelial Ovarian Cancer
por: Matsuo, Koji, et al.
Publicado: (2020)

A critical assessment of SELDI-TOF-MS for biomarker discovery in serum and tissue of patients with an ovarian mass
por: Wegdam, Wouter, et al.
Publicado: (2012)

Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer
por: Maeda, Kazuya, et al.
Publicado: (2020)

Ovarian Cancer Biomarker Discovery Based on Genomic Approaches
por: Lee, Jung-Yun, et al.
Publicado: (2013)

Application of ProteinChip Array Profiling in Serum Biomarker Discovery for Patients Suffering From Severe Acute Respiratory Syndrome
por: Yip, Timothy T. C., et al.
Publicado: (2007)

Mathematical Prognostic Biomarker Models for Treatment Response and Survival in Epithelial Ovarian Cancer
por: Nikas, Jason B., et al.
Publicado: (2011)

Comprehensive analysis of competitive endogenous RNAs networks reveals potential prognostic biomarkers associated with epithelial ovarian cancer
por: Wu, Wenjuan, et al.
Publicado: (2021)

Discovery of candidate tumor biomarkers for treatment with intraperitoneal chemotherapy for ovarian cancer
por: Seagle, Brandon-Luke L., et al.
Publicado: (2016)

Recent advances in the biomarkers for epithelial ovarian cancer
por: Kim, Yun Hwan, et al.
Publicado: (2011)

Discovery of novel glioma serum biomarkers by proximity extension assay
por: Ghorbani, Atefeh, et al.
Publicado: (2023)

Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis
por: Xue, A, et al.
Publicado: (2010)

Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes
por: Teng, P-N, et al.
Publicado: (2014)

Discovery of Novel Serum Biomarkers for Prenatal Down Syndrome Screening by Integrative Data Mining
por: Pennings, Jeroen L. A., et al.
Publicado: (2009)

Biomarker Discovery in Serum from Patients with Carotid Atherosclerosis
por: DeGraba, Thomas J., et al.
Publicado: (2011)

Microcomputers in a water authority laboratory
por: Bertenshaw, M. P., et al.
Publicado: (1985)

In Silico discovery of transcription factors as potential diagnostic biomarkers of ovarian cancer
por: Kaur, Mandeep, et al.
Publicado: (2011)

Understanding Ovarian Cancer: iTRAQ-Based Proteomics for Biomarker Discovery
por: Swiatly, Agata, et al.
Publicado: (2018)

Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis
por: Xiao, Yinan, et al.
Publicado: (2022)

Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer
por: Győrffy, Balázs
Publicado: (2023)

The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma.
por: Fisken, J., et al.
Publicado: (1993)

Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy
por: Hathout, Yetrib, et al.
Publicado: (2015)

Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis
por: Regev, Keren, et al.
Publicado: (2016)

Discovery of Candidate Serum Proteomic and Metabolomic Biomarkers in Ankylosing Spondylitis
por: Fischer, Roman, et al.
Publicado: (2012)

A bespoke target selection tool to guide biomarker discovery in tubo-ovarian cancer
por: Beirne, James P., et al.
Publicado: (2022)

Comprehensive variation discovery in single human genomes
por: Weisenfeld, Neil I., et al.
Publicado: (2014)

Enhancement in Mechanical Properties of Glass/Epoxy Composites by a Hybrid Combination of Multi-Walled Carbon Nanotubes and Graphene Nanoparticles
por: Turaka, Seshaiah, et al.
Publicado: (2023)

Discovery and Validation of Potential Serum Biomarkers with Pro-Inflammatory and DNA Damage Activities in Ulcerative Colitis: A Comprehensive Untargeted Metabolomic Study
por: Li, Mingxiao, et al.
Publicado: (2022)

Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian Cancer
por: Shiao, Meng-Shin, et al.
Publicado: (2021)

Best serum biomarker combination for ovarian cancer classification
por: Song, Hye-Jeong, et al.
Publicado: (2018)

Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum
por: De La Franier, Brian, et al.
Publicado: (2020)

The Serum Glycome to Discriminate between Early-Stage Epithelial Ovarian Cancer and Benign Ovarian Diseases
por: Biskup, Karina, et al.
Publicado: (2014)

Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel
por: Oikonomopoulou, K, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_4r2pglls77fdj7c0lee0lmb043